[Pharmacological properties of reserpine 3,5,3'-triiodothyroacetate].
D000818:Animals; D001794:Blood Pressure / Q000187:drug effects*; D001835:Body Weight / Q000187:drug effects*; D002490:Central Nervous System / Q000187:drug effects*; D004285:Dogs; D004837:Epinephrine / Q000494:pharmacology; D005260:Female; D006993:Hypnotics and Sedatives; D008297:Male; D051379:Mice; D009638:Norepinephrine / Q000494:pharmacology; D011817:Rabbits; D051381:Rats; D012110:Reserpine / Q000008:administration & dosage / Q000494:pharmacology; D046948:Secologanin Tryptamine Alkaloids / Q000008:administration & dosage / Q000494:pharmacology*; D013961:Thyroid Gland / Q000187:drug effects* / Q000378:metabolism; D014665:Vasodilator Agents
D006993:Hypnotics and Sedatives; D046948:Secologanin Tryptamine Alkaloids; D014665:Vasodilator Agents; D012110:Reserpine; D009638:Norepinephrine; D004837:Epinephrine
Des proprietes pharmacologiques de 3,5,3'-triiodothyroacetate de reserpine.